These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29280768)

  • 1. HIV Pre-exposure Prophylaxis Prescribing Through Telehealth.
    Stekler JD; McMahan V; Ballinger L; Viquez L; Swanson F; Stockton J; Crutsinger-Perry B; Kern D; Scott JD
    J Acquir Immune Defic Syndr; 2018 Apr; 77(5):e40-e42. PubMed ID: 29280768
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV pre-exposure prophylaxis (PrEP).
    Tumarkin E; Siedner MJ; Bogoch II
    BMJ; 2019 Jan; 364():k4681. PubMed ID: 30655299
    [No Abstract]   [Full Text] [Related]  

  • 3. Iowa TelePrEP: A Public-Health-Partnered Telehealth Model for Human Immunodeficiency Virus Preexposure Prophylaxis Delivery in a Rural State.
    Hoth AB; Shafer C; Dillon DB; Mayer R; Walton G; Ohl ME
    Sex Transm Dis; 2019 Aug; 46(8):507-512. PubMed ID: 31295217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PrEP: why are we waiting?
    Lancet HIV
    Lancet HIV; 2015 Oct; 2(10):e401. PubMed ID: 26423641
    [No Abstract]   [Full Text] [Related]  

  • 5. This is a story about living-not dying.
    Ranscombe P
    Lancet HIV; 2018 Dec; 5(12):e686. PubMed ID: 30104179
    [No Abstract]   [Full Text] [Related]  

  • 6. Decline in new HIV diagnoses among MSM in Melbourne.
    Chow EPF; Medland NA; Denham I; Wright EJ; Fairley CK
    Lancet HIV; 2018 Sep; 5(9):e479-e481. PubMed ID: 30215345
    [No Abstract]   [Full Text] [Related]  

  • 7. How many MSM in Europe could benefit from PrEP--a 9 billion Euro question?
    Kenyon CR; Osbak K
    Int J STD AIDS; 2015 Nov; 26(13):988-90. PubMed ID: 26490178
    [No Abstract]   [Full Text] [Related]  

  • 8. Preexposure Prophylaxis For HIV Prevention: What We Know and What We Still Need to Know for Implementation.
    Landovitz RJ
    Top Antivir Med; 2015; 23(2):85-90. PubMed ID: 26200708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preference for Condoms, Antiretroviral Preexposure Prophylaxis, or Both Methods to Reduce Risk for HIV Acquisition Among Uninfected US Black and Latino MSM.
    Mansergh G; Herbst JH; Mimiaga MJ; Holman J
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):e153-5. PubMed ID: 26302430
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiretroviral Medications for the Prevention of HIV Infection: A Clinical Approach to Preexposure Prophylaxis, Postexposure Prophylaxis, and Treatment as Prevention.
    Heendeniya A; Bogoch II
    Infect Dis Clin North Am; 2019 Sep; 33(3):629-646. PubMed ID: 31239092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the impact of prioritization of antiretroviral pre-exposure prophylaxis in New York.
    Kessler J; Myers JE; Nucifora KA; Mensah N; Toohey C; Khademi A; Cutler B; Braithwaite S
    AIDS; 2014 Nov; 28(18):2683-91. PubMed ID: 25493594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reaching High-Risk Patients for HIV Preexposure Prophylaxis.
    Riddell J; Cohn JA
    JAMA; 2016 Jul; 316(2):211-2. PubMed ID: 27404188
    [No Abstract]   [Full Text] [Related]  

  • 13. Summary of German-Austrian HIV PrEP guideline.
    Spinner CD; Lang GF; Boesecke C; Jessen H; Schewe K;
    HIV Med; 2019 Jul; 20(6):368-376. PubMed ID: 31140708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory Testing of a Cohort of Commercially Insured Users of HIV Preexposure Prophylaxis in the United States, 2011-2015.
    Huang YA; Tao G; Samandari T; Hoover KW
    J Infect Dis; 2018 Jan; 217(4):617-621. PubMed ID: 29145597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-exposure prophylaxis for MSM and transgender persons in early adopting countries.
    Hoornenborg E; Krakower DS; Prins M; Mayer KH
    AIDS; 2017 Oct; 31(16):2179-2191. PubMed ID: 28991023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PrEP: why we are waiting.
    Jansen MP; Tromp N; Baltussen R
    Lancet HIV; 2016 Jan; 3(1):e11-2. PubMed ID: 26762986
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute hepatitis A breakthrough in MSM in Paris area: implementation of targeted hepatitis A virus vaccine in a context of vaccine shortage.
    Farfour E; Lesprit P; Chan Hew Wai A; Mazaux L; Fourn E; Majerholc C; Bonan B; Vasse M; Zucman D
    AIDS; 2018 Feb; 32(4):531-532. PubMed ID: 29381561
    [No Abstract]   [Full Text] [Related]  

  • 18. How can we improve uptake of oral HIV pre-exposure prophylaxis for transgender individuals?
    Radix AE; Harris AB; Goldstein ZG
    Expert Rev Anti Infect Ther; 2020 Sep; 18(9):835-838. PubMed ID: 32316773
    [No Abstract]   [Full Text] [Related]  

  • 19. CROI 2019: advances in HIV prevention and plans to end the epidemic.
    Buchbinder SP; Liu AY
    Top Antivir Med; 2019 Apr; 27(1):8-25. PubMed ID: 31136999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Review of Telehealth Innovations for HIV Pre-Exposure Prophylaxis (PrEP).
    Touger R; Wood BR
    Curr HIV/AIDS Rep; 2019 Feb; 16(1):113-119. PubMed ID: 30701404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.